Tigulixostat
Appearance
Clinical data | |
---|---|
Other names | LC-350189 |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
ChEMBL | |
Chemical and physical data | |
Formula | C16H14N4O2 |
Molar mass | 294.314 g·mol−1 |
3D model (JSmol) | |
| |
|
Tigulixostat is an investigational new drug that is being evaluated for the treatment of gout.[1] It is a xanthine oxidase inhibitor.[2]
References
[edit]- ^ "Tigulixostat - LG Chem". AdisInsight. Springer Nature Switzerland AG.
- ^ Yip K, Braverman G, Yue L, Fields T (March 2024). "Pipeline Therapies for Gout". Current Rheumatology Reports. 26 (3): 69–80. doi:10.1007/s11926-023-01128-3. PMID 38133712.